Histone 3 Hyperacetylation and the Aggressive Behavior of Giant Cell Lesions
Cancer Medicine · 2026-04 · 15 (4)
DOI: 10.1002/cam4.71785 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 05.04.2026. Verfasst von Caio César da Silva Barros und 4 weiteren Autor:innen. Beteiligte Einrichtung: Epithelial Biology Laboratory, Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Histones, Granuloma, Giant Cell, Bone Neoplasms, Giant Cell Tumor of Bone. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
Introduction
Giant Cell Lesions exhibit variable aggressive clinical behavior. Understanding the molecular mechanisms of these lesions can facilitate a more personalized and effective therapeutic approach. Material and Methods The acetylation of Histone H3 at Lysine 9 (H3K9ac) and the expression of Inhibitor of Growth Protein 5 (ING5) were evaluated in 19 cases of Peripheral Giant Cell Granuloma (PGCG), 19 cases of non‐aggressive Central Giant Cell Granuloma (CGCG), 19 cases of aggressive CGCG, and 19 cases of Giant Cell Tumor of Bone (GCTB), totaling 76 cases of Giant Cell Lesions.
Results
H3K9 hyperacetylation was found in aggressive Giant Cell Lesions compared to non‐aggressive lesions ( p < 0.05). Aggressive Giant Cell Lesions also show higher ING5 expression in multinucleated giant cells and cannibalistic multinucleated giant cells compared to non‐aggressive lesions ( p < 0.05). There was no difference in the levels of H3K9ac and ING5 between aggressive Central Giant Cell Granuloma and Giant Cell Tumor of Bone ( p > 0.05). H3K9ac and ING5 were associated with aggressive characteristics in the CGCG ( p < 0.05).
Conclusion
H3K9 hyperacetylation highlights the significance of this epigenetic event in the aggressiveness of Giant Cell Lesions and may indicate their potential for aggressive behavior, thereby providing information to improve treatment strategies, particularly for Central Giant Cell Granuloma. Understanding the CGCG's clinical behavior is essential for determining the therapeutic modality and avoiding long‐term post‐treatment sequelae.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Epithelial Biology Laboratory, Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry, Ann Arbor, Michigan, USA.
- Postgraduate Program in Dental Sciences, Oral Pathology and Medicine, Department of Dentistry, Federal University of Rio Grande Do Norte, Natal, RN, Brazil.
ORCID-Profile: Caio César da Silva Barros, Éricka Janine Dantas da Silveira, Rogerio Moraes Castilho, Cristiane Helena Squarize
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
da Silva Barros, C. C., da Silveira, É. J. D., da Costa Miguel, M. C., Castilho, R. M., & Squarize, C. H. (2026). Histone 3 Hyperacetylation and the Aggressive Behavior of Giant Cell Lesions. Cancer Medicine, 15(4). https://doi.org/10.1002/cam4.71785
Vancouver
da Silva Barros CC, da Silveira ÉJD, da Costa Miguel MC, Castilho RM, Squarize CH. Histone 3 Hyperacetylation and the Aggressive Behavior of Giant Cell Lesions. Cancer Medicine. 2026;15(4). doi:10.1002/cam4.71785
BibTeX
@article{daSilvaBarros2026,
author = {da Silva Barros, Caio César and da Silveira, Éricka Janine Dantas and da Costa Miguel, Márcia Cristina and Castilho, Rogerio Moraes and Squarize, Cristiane Helena},
title = {Histone 3 Hyperacetylation and the Aggressive Behavior of Giant Cell Lesions},
journal = {Cancer Medicine},
year = {2026},
volume = {15},
number = {4},
doi = {10.1002/cam4.71785}
}
EUVIMED